Andrew Rinderer is a senior recruiter in the biopharmaceutical sector with expertise in talent acquisition for rare cardiopulmonary diseases. His career includes roles at BioAgilytix and ICON plc. He holds a Bachelor of Science and a Graduate Certification from North Carolina State University.
Based in the Research Triangle Park area, Andrew is connected to a major hub for biotechnology and pharmaceutical development. His professional interests include major industry players like AstraZeneca and Eli Lilly and Company.
He is currently focused on scaling manufacturing teams to support the strong demand for life-saving therapies.
Read the full overview →While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They prefer to fully evaluate every situation. They are more likely than others to negotiate on pricing and terms.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.